These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 24040908)

  • 1. The COPD pipeline XXIV.
    Gross NJ
    COPD; 2013 Oct; 10(5):625-7. PubMed ID: 24040908
    [No Abstract]   [Full Text] [Related]  

  • 2. The COPD Pipeline XII.
    Gross NJ; Hanania NA
    COPD; 2011 Oct; 8(5):387-91. PubMed ID: 21905763
    [No Abstract]   [Full Text] [Related]  

  • 3. Drugs for chronic obstructive pulmonary disease.
    Montuschi P
    Curr Med Chem; 2013; 20(12):1461-3. PubMed ID: 23016550
    [No Abstract]   [Full Text] [Related]  

  • 4. Emerging therapeutic strategies in COPD.
    Babu KS; Morjaria JB
    Drug Discov Today; 2015 Mar; 20(3):371-9. PubMed ID: 25462534
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [COPD: LAMA / LABA fixed combination more effective than separately ].
    Steurer J
    Praxis (Bern 1994); 2016 Feb; 105(3):167-8. PubMed ID: 26837326
    [No Abstract]   [Full Text] [Related]  

  • 6. The COPD pipeline x.
    Gross NJ
    COPD; 2011 Jun; 8(3):244-7. PubMed ID: 21561234
    [No Abstract]   [Full Text] [Related]  

  • 7. Novel combined candidate--new hopes for COPD maintenance therapy!?
    Mihălţan F; Ulmeanu R
    Pneumologia; 2015; 64(3):9-11. PubMed ID: 26740985
    [No Abstract]   [Full Text] [Related]  

  • 8. [Fixed combination of long-acting bronchodilators in COPD].
    Steurer J
    Praxis (Bern 1994); 2015 Oct; 104(22):1221. PubMed ID: 26953373
    [No Abstract]   [Full Text] [Related]  

  • 9. Another Choice for Prevention of COPD Exacerbations.
    Donohue JF
    N Engl J Med; 2016 Jun; 374(23):2284-6. PubMed ID: 27181835
    [No Abstract]   [Full Text] [Related]  

  • 10. Multivalent dual pharmacology muscarinic antagonist and β₂ agonist (MABA) molecules for the treatment of COPD.
    Hughes AD; McNamara A; Steinfeld T
    Prog Med Chem; 2012; 51():71-95. PubMed ID: 22520472
    [No Abstract]   [Full Text] [Related]  

  • 11. Review: Combination umeclidinium/vilanterol improved health status more than umeclidinium in COPD.
    Stanbrook MB
    Ann Intern Med; 2015 Dec; 163(12):JC10. PubMed ID: 26666800
    [No Abstract]   [Full Text] [Related]  

  • 12. Emerging trends in the therapy of COPD: bronchodilators as mono- and combination therapies.
    Fitzgerald MF; Fox JC
    Drug Discov Today; 2007 Jun; 12(11-12):472-8. PubMed ID: 17532532
    [TBL] [Abstract][Full Text] [Related]  

  • 13. M(2)-β(2) interaction: a basis for combined bronchodilator treatment.
    López-Campos JL
    Arch Bronconeumol; 2013 Jul; 49(7):279-81. PubMed ID: 23122560
    [No Abstract]   [Full Text] [Related]  

  • 14. Ultra-LAMA, ultra-LABA, ultra-inhaled steroids? The future has landed.
    Domingo C
    Arch Bronconeumol; 2013 Apr; 49(4):131-4. PubMed ID: 23415574
    [No Abstract]   [Full Text] [Related]  

  • 15. In vitro anti-inflammatory effects of AZD8999, a novel bifunctional muscarinic acetylcholine receptor antagonist /β2-adrenoceptor agonist (MABA) compound in neutrophils from COPD patients.
    Milara J; Contreras S; de Diego A; Calbet M; Aparici M; Morcillo E; Miralpeix M; Cortijo J
    PLoS One; 2019; 14(1):e0210188. PubMed ID: 30608978
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Future of Triple Therapy in chronic obstructive pulmonary disease.
    Alcázar-Navarrete B; Castellano Miñán F; Romero Palacios PJ
    Arch Bronconeumol (Engl Ed); 2018 Feb; 54(2):63-64. PubMed ID: 28760570
    [No Abstract]   [Full Text] [Related]  

  • 17. An integrated approach to the medical treatment of chronic obstructive pulmonary disease.
    Rosenberg SR; Kalhan R
    Med Clin North Am; 2012 Jul; 96(4):811-26. PubMed ID: 22793946
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The use of long acting β₂-agonists, alone or in combination with inhaled corticosteroids, in chronic obstructive pulmonary disease (COPD): a risk-benefit analysis.
    Cave AC; Hurst MM
    Pharmacol Ther; 2011 May; 130(2):114-43. PubMed ID: 21276815
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Advances in drug delivery: Is triple therapy the future for the treatment of chronic obstructive pulmonary disease?
    Salama RO; Young PM; Rogueda P; Lallement A; Iliev I; Traini D
    Expert Opin Pharmacother; 2011 Aug; 12(12):1913-32. PubMed ID: 21714776
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Dual bronchodilators becomes the first choice combination].
    Einecke D
    MMW Fortschr Med; 2016 Jun; 158(11):18. PubMed ID: 27271388
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.